ScirosBio is an acronym of “Science of ROS Biology”. Our team has in-depth scientific knowledge in ROS biology, ROS contributions to disease manifestations and ROS modulating drugs. Due to the predominant role of ROS signaling in cancer and other diseases, we at ScirosBio developing drugs targeting ROS signaling.
We developed a ROS paradigm-guided Antioxidants-based Intervention platform for Diseases (RAID technology platform) that utilizes a combination of ROS modulating small molecules synergistically with other standard-of-care (SoC) to enhance the treatment outcome.